Form 8-K - Current report:
SEC Accession No. 0001860742-25-000019
Filing Date
2025-08-18
Accepted
2025-08-18 17:06:46
Documents
14
Period of Report
2025-08-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blco-20250814.htm   iXBRL 8-K 30942
2 EX-99.1 blpressrelease.htm EX-99.1 8229
6 BL LOGO bllogo-hiresa.jpg GRAPHIC 223158
  Complete submission text file 0001860742-25-000019.txt   460425

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blco-20250814.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blco-20250814_lab.xml EX-101.LAB 22490
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blco-20250814_pre.xml EX-101.PRE 13030
17 EXTRACTED XBRL INSTANCE DOCUMENT blco-20250814_htm.xml XML 2791
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)